Show simple item record

dc.contributor.authorMilicic, A
dc.contributor.authorRollier, CS
dc.contributor.authorTang, CK
dc.contributor.authorLongley, R
dc.contributor.authorHill, AVS
dc.contributor.authorReyes-Sandoval, A
dc.date.accessioned2020-12-10T00:36:58Z
dc.date.available2020-12-10T00:36:58Z
dc.date.issued2017-08-04
dc.identifierpii: 10.1038/s41598-017-07246-0
dc.identifier.citationMilicic, A., Rollier, C. S., Tang, C. K., Longley, R., Hill, A. V. S. & Reyes-Sandoval, A. (2017). Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria. SCIENTIFIC REPORTS, 7 (1), https://doi.org/10.1038/s41598-017-07246-0.
dc.identifier.issn2045-2322
dc.identifier.urihttp://hdl.handle.net/11343/253528
dc.description.abstractThe majority of routinely given vaccines require two or three immunisations for full protective efficacy. Single dose vaccination has long been considered a key solution to improving the global immunisation coverage. Recent infectious disease outbreaks have further highlighted the need for vaccines that can achieve full efficacy after a single administration. Viral vectors are a potent immunisation platform, benefiting from intrinsic immuno-stimulatory features while retaining excellent safety profile through the use of non-replicating viruses. We investigated the scope for enhancing the protective efficacy of a single dose adenovirus-vectored malaria vaccine in a mouse model of malaria by co-administering it with vaccine adjuvants. Out of 11 adjuvants, only two, Abisco®-100 and CoVaccineHTTM, enhanced vaccine efficacy and sterile protection following malaria challenge. The CoVaccineHTTM adjuvanted vaccine induced significantly higher proportion of antigen specific central memory CD8+ cells, and both adjuvants resulted in increased proportion of CD8+ T cells expressing the CD107a degranulation marker in the absence of IFNγ, TNFα and IL2 production. Our results show that the efficacy of vaccines designed to induce protective T cell responses can be positively modulated with chemical adjuvants and open the possibility of achieving full protection with a single dose immunisation.
dc.languageEnglish
dc.publisherNATURE PUBLISHING GROUP
dc.titleAdjuvanting a viral vectored vaccine against pre-erythrocytic malaria
dc.typeJournal Article
dc.identifier.doi10.1038/s41598-017-07246-0
melbourne.affiliation.departmentMedical Biology (W.E.H.I.)
melbourne.source.titleScientific Reports
melbourne.source.volume7
melbourne.source.issue1
dc.rights.licenseCC BY
melbourne.elementsid1320743
melbourne.contributor.authorLongley, Rhea
dc.identifier.eissn2045-2322
melbourne.accessrightsOpen Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record